Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey

Background Alternative models for methadone delivery outside of federal and state-regulated opioid treatment programs may improve access. We determined factors associated with clinician support for continuing office-based methadone. Methods We used data from the electronic Opioid Use Disorder Provider COVID-19 Survey conducted among X-waivered clinicians who were providing outpatient, longitudinal treatment of opioid use disorder (OUD) from July 2020 to August 2020. The outcome variable was selecting "The opportunity for patients to receive office-based methadone"when asked "Which pandemic-related policy changes or new policy changes would you like to be continued or started after the pandemic?"Using sequential multivariable logistic regression modeling, we estimated the association between clinician and practice characteristics and support for office-based methadone. Results Of 1900 respondents, 728 met the inclusion criteria. Twenty-eight percent indicated support for office-based methadone. Clinician characteristics associated with support for office-based methadone were being Black or African American versus White (adjusted odds ratio [AOR] [95% confidence interval (CI)], 2.88 [1.19-6.98]), having provided medications for OUD (MOUD) for >15 years versus ≤15 years (AOR [95% CI], 1.66 [1.02-2.68]), treating 51 to 100 patients with MOUD monthly versus <25 patients (AOR [95% CI], 1.79 [1.04-3.09]), providing methadone (AOR [95% CI], 1.71 [1.03-2.85]) versus not providing MOUD previously, and working in an academic medical center versus other settings (AOR [95% CI], 1.88 [1.11-3.16]). Conclusions A minority of surveyed X-waivered clinicians supported office-based methadone. Efforts to expand access to methadone via office-based settings should address implementation barriers.

This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Addiction Medicine. The published version of record [Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey. Journal of Addiction Medicine (2024)] is available online at: 10.1097/ADM.0000000000001388.

Files

  • View: AcceptedVersionJAM2024.pdf

    Download: AcceptedVersionJAM2024.pdf

    size: 761 KB | mime_type: application/pdf | date: 2025-01-30 | sha256: c85a1ac | Request alternate format

Metadata

Work Title Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey
Access
Open Access
Creators
  1. Minhee L. Sung
  2. Anne C. Black
  3. Derek Blevins
  4. Brandy F. Henry
  5. Kathryn Cates-Wessel
  6. Michael A. Dawes
  7. Holly Hagle
  8. Paul J. Joudrey
  9. Todd Molfenter
  10. Frances R. Levin
  11. David A. Fiellin
  12. E. Jennifer Edelman
Keyword
  1. opioid use disorder
  2. methadone
  3. medications for opioid use disorder
  4. survey
  5. COVID-19
License In Copyright (Rights Reserved)
Work Type Article
Publisher
  1. Journal of Addiction Medicine
Publication Date 2024
Publisher Identifier (DOI)
  1. https://doi.org/10.1097/ADM.0000000000001388
Deposited January 30, 2025

Versions

Analytics

Collections

This resource is currently not in any collection.

Work History

Version 1
published

  • Created
  • Added AcceptedVersionJAM2024.pdf
  • Added Creator Minhee L. Sung
  • Added Creator Anne C. Black
  • Added Creator Derek Blevins
  • Added Creator Brandy F. Henry
  • Added Creator Kathryn Cates-Wessel
  • Added Creator Michael A. Dawes
  • Added Creator Holly Hagle
  • Added Creator Paul J. Joudrey
  • Added Creator Todd Molfenter
  • Added Creator Frances R. Levin
  • Added Creator David A. Fiellin
  • Added Creator E. Jennifer Edelman
  • Published
  • Updated
  • Updated Keyword, Publication Date Show Changes
    Keyword
    • opioid use disorder, methadone, medications for opioid use disorder, survey, COVID-19
    Publication Date
    • 2024-10-30
    • 2024